| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |